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ttp://dx.doi.org/10.1016/j.ajpath.2014.01.020Alcohol-induced liver ﬁbrosis and eventually cirrhosis is a leading cause of death. Acetaldehyde, the
ﬁrst metabolite of ethanol, up-regulates expression of the human a2(I) collagen gene (COL1A2). Early
acetaldehyde-mediated effects involve phosphorylation and nuclear translocation of SMAD3/4econtaining
complexes that bind to COL1A2 promoter to induce ﬁbrogenesis. We used human and mouse hepatic
stellate cells to elucidate the mechanisms whereby acetaldehyde up-regulates COL1A2 by modulating
the role of Ski and the expression of SMADs 3, 4, and 7. Acetaldehyde induced up-regulation of
COL1A2 by 3.5-fold, with concomitant increases in the mRNA (threefold) and protein (4.2- and 3.5-
fold) levels of SMAD3 and SMAD4, respectively. It also caused a 60% decrease in SMAD7 expression.
Ski, a member of the Ski/Sno oncogene family, is colocalized in the nucleus with SMAD4. Acetal-
dehyde induces translocation of Ski and SMAD4 to the cytoplasm, where Ski undergoes proteasomal
degradation, as conﬁrmed by the ability of the proteasomal inhibitor lactacystin to blunt up-
regulation of acetaldehyde-dependent COL1A2, but not of the nonspeciﬁc ﬁbronectin gene (FN1).
We conclude that acetaldehyde up-regulates COL1A2 by enhancing expression of the transactivators
SMAD3 and SMAD4 while inhibiting the repressor SMAD7, along with promoting Ski translocation from
the nucleus to cytoplasm. We speculate that drugs that prevent proteasomal degradation of re-
pressors targeting COL1A2 may have antiﬁbrogenic properties. (Am J Pathol 2014, 184: 1458e1467;
http://dx.doi.org/10.1016/j.ajpath.2014.01.020)Supported in part by NIH grants AA-010541 and AA-009231 (M.R.L.),
a grant-in aid from the Ministry of Education, Culture, Sports, Science and
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M.R. is deceased.Alcohol-induced liver ﬁbrosis is a multifactorial event char-
acterized by increased collagen production as a result of up-
regulation of a2(I) collagen (COL1A2) gene.1 This is induced
primarily by its immediate oxidation product, acetaldehyde,
as well as by other events occurring during alcohol meta-
bolism, such as changes in redox state,2 formation of free
radicals and generation of reactive oxygen species,2e4
and depletion of antioxidant defenses and generation of
aliphatic aldehydes derived from lipid peroxidation (namely,
4-hydroxy-nonenal andmalonyldialdehyde).5 Because ethanolstigative Pathology.
.
Up-Regulation of COL1A2 in HSCsalso increases the circulationofbacterial-derivedendotoxin,6e8
and this in turn up-regulates expression of inﬂammatory cy-
tokines, the aforementioned events also play a role in the in-
ﬂammatory response and therefore in ﬁbrogenesis and
complications resulting from chronic alcoholic liver disease.7,9
To unravel key molecular mechanisms involved in
acetaldehyde-mediated up-regulation of type I collagen, we
have investigated thekey roles playedby this ethanolmetabolite
in up-regulation of type I collagen genes in hepatic stellate cells
(HSCs).1 We have shown that several different transcription
factors are involved in acetaldehyde-dependent up-regulation of
the type I collagen genes. Although CAAT/enhancing binding
protein p35S (p35C/EBPb) is required for expression of
the a1(I) collagen mRNA,10 Sp1 and SMAD3 are essential for
up-regulation of COL1A2 gene.11 We and others have also
shown that reactive oxygen species in general,2e4 and H2O2 in
particular, play a key role in the acetaldehyde-elicited response
and that H2O2 acts as a secondmessenger in both acetaldehyde-
dependent and transforming growth factor b1 (TGF-b1)e
dependent up-regulation of type I collagen genes.2,10
Acetaldehyde up-regulates expression ofCOL1A2 gene via
a de novo protein synthesiseindependent, PI3K-dependent
mechanism.12 In addition, the early acetaldehyde-mediated
effects, occurring during the ﬁrst 6 to 12 hours after acetal-
dehyde treatment, are independent of TGF-b1.12 However,
the mechanisms whereby acetaldehyde modulates expression
and activity of members of the SMAD family, including
SMAD3, SMAD4, and SMAD7, leading to COL1A2 up-
regulation are not well understood. Here, we show that
SMAD3 andSMAD4 are the limiting factors inCOL1A2 gene
up-regulation and that this ethanol metabolite enhances
expression of SMAD3 and SMAD4 at the mRNA and protein
levels.
c-Ski, a homolog of v-Ski in cells and a versatile transcrip-
tional regulator that is widely distributed in different tissues, has
been reported to be a corepressor of TGF-b/SMAD signaling.13
BindingofTGF-b to its receptor serine/threoninekinases results
in the regulation of SMAD2 and SMAD3 proteins. The phos-
phorylated SMADs then form heteromeric complexes with a
common mediator SMAD4 (co-SMAD).14 Together, they
translocate into the nucleus, where they bind to DNA and
activate transcription of the target genes.15We further show that
Ski, a member of the Ski/Sno family of oncogenes, is colo-
calized in the nucleus with SMAD4 and that acetaldehyde in-
duces their cotranslocation to the cytosol, where Ski is degraded
by proteasomes. We also demonstrate that inhibiting proteaso-
mal degradation of Ski by lactacystin blunts the acetaldehyde-
dependent up-regulation of COL1A2 gene, but has no effect
on expression of the nonspeciﬁc protein ﬁbronectin.
Materials and Methods
Plasmids and Reagents
TGF-b1 was purchased from Roche Diagnostics (Indian-
apolis, IN). Lactacystin was purchased from CalbiochemeThe American Journal of Pathology - ajp.amjpathol.orgNovabiochem (Millipore, Billerica, MA). Acetaldehyde was
purchased from Thermo Fisher Scientiﬁc (Waltham, MA).
The construction of the378COL1A2LUCchimeric plasmid
containing the 378 to þ54 region of COL1A2 linked to the
ﬁreﬂy luciferase gene has been described previously.12
SMAD3, -4, and -7 expression plasmids cloned into the
pcDNA3 cytomegalovirus expression vector (Life Technol-
ogies, Carlsbad, CA) have been described previously.11,16
The cDNAs of COL1A2, ﬁbronectin, and TGF-b1 have
been described previously.17e19 S14 ribosomal protein
cDNA was obtained from ATCC (Manassas, VA). cDNA
fragments of human SMAD3 (nucleotides 501 to 878) and
SMAD4 (nucleotides 601 to 1050) were used to determine
steady-state levels of SMAD3 and SMAD4 mRNAs.
Nonspeciﬁc IgG rabbit, mouse, and goat polyclonal anti-
bodies against Ski (sc-9140), SMAD3 (sc-101154), and
SMAD4 (sc-1909), respectively, were obtained from Santa
Cruz Biotechnology (Dallas, TX). Neutralizing antibody to
TGF-b1 was obtained from Promega (Madison, WI).
HHSC Isolation and Culture
HumanHSCs (HHSCs)were isolated from a consenting study
subject with clinically proven normal healthy liver during
gastric bypass surgery for morbid obesity as described pre-
viously.1 Informed consent in writing was obtained from the
study patient, and the study protocol conformed to the ethical
guidelines of the 1975Declaration of Helsinki as reﬂected in a
prior approval by the Institutional Review Committee. For
some experiments, mouse HSCs were isolated as described
previously.20 Cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal bovine serum
(HyClone; Thermo Fisher Scientiﬁc, Waltham, MA) and
antibiotics. Experiments were performed in triplicate, using
cells obtained from at least three different patients cultured for
2 to 8 passages.
Northern Blot Hybridization and Run-On Transcription
Assay
Conﬂuent HHSCs were placed in a serum-free medium
containing glutamine, nonessential amino acids, and anti-
biotics. Approximately 14 hours later, acetaldehyde was
added at a ﬁnal concentration of 200 mmol/L. Viability of
cells was estimated using the trypan blue exclusion test. In
all cases, cellular viability was greater than 90%. Total RNA
was extracted at 30 minutes and 1, 3, 24, and 48 hours and
was processed for Northern blot hybridizations according to
standard protocols.12 Likewise, a standard protocol was
used to determine rates of COL1A2, ﬁbronectin, and TGF-
b1 transcription in control and acetaldehyde-treated cells,
using S14 and pBR322 DNA as controls.11
In some run-on transcription experiments, cells were pre-
incubated with 30 mmol/L lactacystin for 2 hours before
acetaldehyde administration; in others, cells were pre-
incubated for 2 hours with a neutralizing antibody to TGF-b11459
Figure 1 Effect of acetaldehyde, TGF-b1, or the two in combination on
the expression of a reporter vector driven by the 378COL1A2 promoter in
HSCs. First, HHSCs were transfected with the reporter vector. Next, 12 hours
later, cells were incubated with either 100 mmol/L acetaldehyde, 4 ng/mL
TGF-b1, or both. Then, 36 hours later, cells were harvested and luciferase
activity was determined. Cells treated with the combination of acetalde-
hyde and TGF-b1 showed a 4.2-fold increase in reporter activity. Controls
were transfected cells without treatment. Data are expressed as means 
SEM. *P < 0.05 versus control.
Reyes-Gordillo et al(Promega) or an unrelated IgG (Santa Cruz Biotechnology) at
a ﬁnal concentration of 5 mg/mL. To determine the effec-
tiveness of the antieTGF-b1 antibody, some HHSCs were
also incubated with 8 ng/mL of recombinant TGF-b1 in the
presence or absence of the corresponding neutralizing anti-
body, or an unrelated IgG, according to a protocol described
previously.21 Nuclei were isolated at 15 and 30 minutes and
were used in run-on transcription assays as described previ-
ously.12 Relative intensity of the signals was determined by
laser densitometric analysis of the radiographic ﬁlms. Data
were corrected for loading differences, using S14 as control.
RT-PCR Analysis
Transcript levels of SMADs 3, 4, and 7 in HHSCs were
measured using a quantitative RT-PCR technique (RT-
qPCR). Experiments were performed as described previ-
ously.22 Primer sequences for qPCR ampliﬁcation were as
follows: SMAD3 mRNA , forward 50-GAGGGCAGGCT-
TGGGGAAAATG-30 and reverse 50-GGGAGGGTGCCG-
GTGGTGTAATAC-30; SMAD4 mRNA, forward 50-AAA-
GGTGAAGGTGATGTTTGGGTC-30 and reverse 50-CT-
GGAGCTATTCCACCTACTGATCC-30; SMAD7 mRNA,
forward 50-CGAGACCCTTCTCACTCCTG-30 and reverse
50-GCATCCTTGGTTAGGGTCAA-30; and GAPDH mRNA,
forward 50-GGCCTCCAAGGAGTAAGACC-30 and reverse
50-CTGTGAGGAGGGGAGATTTCA-30. All reagents were












Total, nuclear, and cytosolic extracts were prepared from
control and acetaldehyde-treated HHSCs as described previ-
ously.1,12 In some experiments, HHSCs were treated with 8
ng/mL recombinant TGF-b1; in other experiments, cells were
preincubated for 60 minutes with 30 mmol/L lactacystin
before administration of acetaldehyde or TGF-b1. Total ex-
tracts (20 mg) were separated by SDS-PAGE on 10% gels,
transferred onto a nitrocellulose membrane, and probed with
SMAD3 or SMAD4 goat antibodies (1:1000; Santa Cruz
Biotechnology), followed by incubation with horseradish
peroxidaseeconjugated rabbit anti-goat IgG (1:5000; Santa
Cruz Biotechnology). Nuclear and cytosolic extracts were
separated by SDS-PAGE on 4% to 12% gels, transferred
onto polyvinylidene diﬂuoride membranes, and probed with
Ski rabbit antibody (1:1000; Santa Cruz Biotechnology),
followed by incubation with horseradish peroxidasee
conjugated chicken anti-rabbit secondary antibody (1:2000;
Santa Cruz Biotechnology). Proteins were detected with a
NEN Life Science Products Renaissance enhanced chem-
iluminescence system (PerkinElmer, Waltham, MA), ac-
cording to the manufacturer’s recommendations.1460Coimmunoprecipitation of Ski with SMAD4 and 20S
Proteasome
The coimmunoprecipitation experiment was perform-
ed as described previously.23 In brief, SMAD4 was
immunoprecipitated with a SMAD4 antibody (Santa Cruz
Biotechnology) bound to protein L-agarose beads (Santa
Cruz Biotechnology), and the amount of Ski coimmuno-
precipitated with SMAD4 was quantiﬁed by Western anal-
ysis using Ski antibody (1:1000; Santa Cruz Biotechnology).
Cell Transfections
Conditions for the preparation and transfection of plasmids
into HHSCs by the calcium phosphate procedure have been
described previously.12,16 HHSCs were treated with 10%
glycerol for 90 seconds, at 6 hours after transfection, and
then were placed in medium containing 0.1% fetal bovine
serum. Twelve hours later, acetaldehyde was added at the
ﬁnal concentration of 200 mmol/L, unless otherwise indi-
cated. For some experiments, 8 ng/mL TGF-b1 (unless
otherwise indicated) was added, alone or in combination
with acetaldehyde. Cells were procured at 36 hours after the
addition of acetaldehyde and were used to determine lucif-
erase activity as described previously.
In some experiments, cells were preincubated for 60 mi-
nutes with 30 mmol/L lactacystin before administration of
acetaldehyde. Transcriptional activity of acetaldehyde of the
chimeric constructs was normalized against cotransfected
pSV2CAT. Transfections were performed multiple times and
in duplicate. For some experiments, HHSCs were cotrans-
fected with 7.0 mg of the 378COL1A2LUC reporter
construct and 2.5 mg of a SMAD4 vector, followed by treat-
ment with acetaldehyde using the conditions described above.
For other experiments, HHSCs were cotransfected with 7.0ajp.amjpathol.org - The American Journal of Pathology
Figure 2 TGF-b1 is involved in late acetaldehyde-dependent up-
regulation of COL1A2. Run-on transcription assays of control (white bars;
untreated cells in serum-free medium) and acetaldehyde-treated (black
bars) HHSCs for 24 hours in the presence or absence of a nonspeciﬁc IgG or
a neutralizing antibody to TGF-b1 (gray bars; antieTGF-b1). As a control
for these experiments, some HSCs were treated with 2 ng/mL of TGF-b1 in
the absence or presence of the neutralizing antibody to the cytokine.
COL1A2 gene transcription was up-regulated 3.5-fold by acetaldehyde,
whereas the neutralizing antibody to TGF-b1 strongly inhibited COL1A2
gene transcription in cells treated with acetaldehyde by 60%. The
nonspeciﬁc immunoglobulin had no effect. Data are expressed as means 
SEM. *P < 0.05 versus control. yP < 0.05 versus acetaldehyde-treated cells.
Up-Regulation of COL1A2 in HSCsmg of the378COL1A2LUC reporter construct and 2.5 mg of
vectors overexpressing SMAD3, SMAD4, both SMAD3 and
SMAD4, or SMAD7, followed by treatment with acetalde-
hyde using the conditions described above.Immunostaining
Mouse HSCs plated on coverslips were ﬁxed with 4%
paraformaldehyde for 10 minutes, permeabilized with
20C cold acetone for 30 minutes, rinsed with PBS, and
blocked with 3% bovine serum albuminePBS for 1 hour.
After blocking, cells were incubated overnight with a goat
polyclonal antibody against Ski (1:10) and rabbit polyclonal
antibody against SMAD4 (1:10), followed by the appropriate
ﬂuorophore-conjugated secondary antibody for 1 hour
(1:300); between acetaldehyde procedures, coverslips were
washed with 0.1% Tween 20ePBS and mounted on glassFigure 3 Increase in SMAD3 and SMAD4 mRNA and protein is delayed after ac
expression levels after acetaldehyde treatment. Total RNA obtained from HHSCs
ranging from 30 minutes to 48 hours was used to determine steady-state levels of
used to obtain cell extracts and to determine levels of SMAD3 and SMAD4 protein
control (A); yP < 0.05 versus 30-minute time point (B).
The American Journal of Pathology - ajp.amjpathol.orgslides with Gel-Mount medium (BioMeda, Foster City, CA).
Images were captured using an AX70 light microscope
(Olympus, Tokyo, Japan) and were processed with Photo-
shop software version 5.0.2 (Adobe Systems, San Jose, CA).
Statistical Analysis
Statistical differences between experimental groups were
analyzed by Student’s t-test (normally distributed data with
equal variances) or U test (normally distributed data with
different variances). All P values of 0.05 were considered
signiﬁcant. Data represent three to six independent experi-
ments using HHSCs obtained from a single patient. Data are
expressed as means  SEM.
Results
Acetaldehyde and TGF-b1 Have an Additive Effect on
Expression of a Reporter Vector Driven by the
Acetaldehyde-Responsive Element 378COL1A2LUC
Because TGF-b1 also induced expression of SMADs 3 and 4,
and given that the acetaldehyde and TGF-b1 responsive el-
ements are localized in the same region of the COL1A2
promoter, it was important to determine whether acetalde-
hyde and TGF-b1 up-regulation of COL1A2 gene expression
is additive or synergistic. To this end, we transfected HSCs
with the378COL1A2LUC reporter vector and treated these
cells with 100 mmol/L acetaldehyde, 4 ng/mL TGF-b1, or
both. It is important to note that the doses used were half of
those normally used in our previous experiments,12 and we
therefore expected a weaker individual response. Neither
acetaldehyde nor TGF-b1 alone was sufﬁcient to up-regulate
expression of the COL1A2 reporter vector to previously
observed levels (Figure 1).12 However, cells treated with the
combination of acetaldehyde and TGF-b1 responded with a
4.2-fold increase in reporter activity (P < 0.05), indicating
that acetaldehyde and TGF-b1 have an additive stimulatory
effect on the activity of COL1A2 reporter vector.etaldehyde treatment. A: Time-course analysis of SMAD3 and SMAD4 mRNA
cultured in the absence or presence of 200 mmol/L acetaldehyde for times
SMAD3 and SMAD4 mRNAs by using RT-PCR analysis. B: Replica dishes were
by Western analysis. Data are expressed as means  SEM. *P < 0.05 versus
1461
Figure 4 SMAD3 and SMAD4 are limiting factors for acetaldehyde-
mediated COL1A2 up-regulation in HSCs. Effect of acetaldehyde on lucif-
erase activity of HSCs transiently cotransfected with 7 mg 378COL1A2LUC
reporter vector and either a control empty cytomegalovirus vector or 2.5 mg
expression vectors for SMAD3 or SMAD4. At 12 hours after transfection, cells
were treated with 200 mmol/L acetaldehyde for 36 hours. Cells were harvested
and used to measure luciferase activity. Up-regulation of either SMAD3 or
SMAD4 alone does not signiﬁcantly enhance reporter activity induced by
acetaldehyde; however, in HHSCs cotransfected with both the reporter vector
and the two vectors expressing SMAD3 and SMAD4, reporter activity increased
twofold, comparedwith that induced byacetaldehyde aloneor cells expressing
either SMAD3 or SMAD4. Data are expressed as means  SEM. *P < 0.05.
Figure 5 Acetaldehyde modulates SMAD7 expression. A: Total RNA was
obtained from HHSCs cultured in the absence or presence of 200 mmol/L
acetaldehyde for times ranging from 30 minutes to 48 hours. Acetaldehyde
down-regulates the expression of SMAD7 mRNA in a time-dependent manner,
reaching the maximum down-regulation of 60% after 3 hours, relative to the
value at 30minutes, after which time expression increases steadily and reaches
values threefold above basal levels by 48 hours. SMAD7mRNA expression levels
were corrected for differences in loading using GAPDH as a housekeeping gene.
*P < 0.05 versus control. B: HHSCs were transiently cotransfected with the
378COL1A2 reporter plasmid and a cytomegalovirus-driven SMAD7 expres-
sion vector. At 12 hours after transfection, cells were treated with 200 mmol/L
acetaldehyde for 36 hours. Cells were harvested and used tomeasure luciferase
activity. Acetaldehyde failed to up-regulate the expression of COL1A2 reporter
vector in HHSCs cotransfected with a vector overexpressing SMAD7 and the
378COL1A2LUC reporter vector. Data are expressed as means  SEM.
*P < 0.05 versus acetaldehyde-treated empty vector. AU, arbitrary units.
Reyes-Gordillo et alThe Late Acetaldehyde-Dependent Up-Regulation of
COL1A2 Transcription Is Mediated by TGF-b1
We have shown that acetaldehyde is directly responsible for
the early expression of a2(I) collagen mRNA and for
changes in cell signaling occurring early (before 6 to 12
hours). However, the late events appear to be associated
with acetaldehyde-induced expression of TGF-b1. To
test this possibility, we measured the late acetaldehyde-
dependent transcription of COL1A2 gene in the presence of
a TGF-b1 neutralizing antibody. We used a nonspeciﬁc
immunoglobulin as a control for these experiments. Tran-
scription of COL1A2 was up-regulated 3.5-fold by acetal-
dehyde (P < 0.05) (Figure 2). Whereas the neutralizing
antibody to TGF-b1 strongly inhibited COL1A2 gene tran-
scription of cells treated with acetaldehyde by 60%
(P < 0.05), the nonspeciﬁc immunoglobulin had no effect.
Acetaldehyde Induces the Late Expression of SMAD3
and SMAD4 mRNAs in HSCs
We have already shown that acetaldehyde induces formation
of SMAD3/4 complexes that bind to the COL1A2 promoter
and phosphorylates SMAD3.12 Thus, we considered it
important to investigate whether acetaldehyde induces
expression of SMADs 3 and 4 and whether this is an early
event directly induced by acetaldehyde per se or a late event
resulting from up-regulation of TGF-b1. We determined the
time course of expression of SMAD3 and SMAD4 mRNA
and protein in HHSCs incubated with acetaldehyde. Acetal-
dehyde up-regulated the mRNA expression of SMADs 3 and
4 approximately threefold (P < 0.05 for both) and up-1462regulated SMAD3 protein expression 4.2-fold (P < 0.05)
and SMAD4 protein expression 3.5-fold (P < 0.05)
(Figure 3). This effect was observed by approximately 24
hours after incubation with acetaldehyde and lasted up to 48
hours, a time period that coincided with acetaldehyde-
induced up-regulation of TGF-b1 mRNA expression.
Both SMAD3 and SMAD4 Are Limiting Factors in
Acetaldehyde-Elicited Up-Regulation of COL1A2
To further test the requirement of SMAD3 and SMAD4
in acetaldehyde-elicited up-regulation of COL1A2, we
cotransfected HHSCs with the 378COL1A2LUC reporter
vector and a vector that overexpressed either SMAD3 or
SMAD4 and determined the reporter activity in cells treated
with or without 200 mmol/L acetaldehyde. Overexpression of
either SMAD3 or SMAD4 alone did not signiﬁcantly
enhance reporter activity induced by acetaldehyde. However,
when HHSCs were cotransfected with the reporter vector andajp.amjpathol.org - The American Journal of Pathology
Figure 6 Acetaldehyde modiﬁes cellular distribution
of Ski. Immunoﬂuorescence microscopy of mouse HSCs
cultured in the absence or presence of 200 mmol/L acetal-
dehyde for 30 minutes. Cells were ﬁxed and stained with a
rabbit anti-Ski antibody followed by a Cy3 (red) labeled
anti-rabbit immunoglobulin. Although ﬂuorescence in con-
trol untreated cells was concentrated predominantly in the
nuclei, in acetaldehyde-treated cells the intensity of the
nuclear signal decreased and the cytosol signal increased. In
addition, acetaldehyde-treated cells appear more granular
and diffused (arrows). Original magniﬁcation, 20.
Up-Regulation of COL1A2 in HSCsalso the two vectors expressing SMAD3 and SMAD4, there
was a twofold increase in reporter activity (P < 0.05),
compared with that induced by acetaldehyde alone or cells
expressing either SMAD3 or SMAD4 (Figure 4).
Acetaldehyde Down-Regulates Expression of SMAD7
and Overexpression of SMAD7 Blunts Up-Regulation of
COL1A2
We and others have shown that SMAD7 is a repressor of
collagen gene expression.24,25 In the present study, therefore,
we investigated whether acetaldehyde has any effect on
expression of SMAD7. Acetaldehyde down-regulated expres-
sion of SMAD7mRNA in a time-dependent manner, reaching
themaximumdown-regulation of60%(P< 0.05) after 3 hours,
relative to the value at 30minutes, after which time it increased
steadily and reached values threefold (P < 0.05) above basal
levels by 48 hours (Figure 5A). Interestingly, when HHSCs
were cotransfected with both a vector overexpressing SMAD7
and the 378COL1A2LUC reporter vector, acetaldehyde
failed to up-regulate expression of COL1A2 reporter vector
(Figure 5B). Overall, these ﬁndings suggest that acetaldehyde
stimulates COL1A2 gene expression at least in part by down-
regulating expression of SMAD7 mRNA.
Ski, a Known Repressor of TGF-b1eResponsive Genes,
Is Colocalized with SMAD4 in the Nucleus
Ski/SnoN is a member of an oncogene family of proteins
that are involved in TGF-b1emediated transcription and
repression of some cytokine target genes.26 In mouseFigure 7 Acetaldehyde and TGF-b1 down-regulate the expression of Ski in HSC
15 (A) and 30 minutes (B) and in cytosolic extracts at 15 (C) and 30 minutes (D)
Data are expressed as means  SEM of triplicate experiments. *P < 0.05, ***P
The American Journal of Pathology - ajp.amjpathol.orgmyoblasts, the activity of Ski is mediated primarily through
its binding with SMAD4 (but not with SMAD2).14 Having
found that acetaldehyde-mediated up-regulation of COL1A2
requires SMAD4, we next investigated whether mouse
HSCs also express Ski and whether acetaldehyde has any
effect on its expression and subcellular localization.
Immunocytochemical analysis of control and acetaldehyde-
treated mouse HSCs revealed that Ski is localized mainly in
the nucleus. With acetaldehyde treatment, however, Ski is
translocated to the cytosol, where it has a granular appear-
ance and extends from the perinuclear area to the plasma
membrane (Figure 6).
To determine whether Ski cytosolic translocation could
be clinically relevant, we analyzed Ski status in response to
acetaldehyde and TGF-b1 in HHSCs. Western blot analysis
of nuclear Ski in control, acetaldehyde-treated, and TGF-
b1etreated HHSCs revealed that nuclear Ski decreased by
40% (P < 0.05) within 15 minutes and by 80% (P < 0.05)
after 30 minutes of TGF-b1 treatment, compared with
control. By contrast, acetaldehyde treatment decreased nu-
clear Ski by 40% (P < 0.05) of the control by 15 minutes,
and had not decreased further at 30 minutes (Figure 7, A and
B). As a consequence of Ski nuclear translocation, cytosolic
Ski increased threefold (P < 0.001) after 15 minutes of
acetaldehyde exposure and ﬁvefold (P < 0.001) after 15
minutes of TGF-b1 treatment. Signiﬁcantly, cytosolic Ski
increased by ninefold with acetaldehyde and TGF-b1
treatment within 30 minutes (P < 0.05 and P < 0.05,
respectively) (Figure 7, C and D).
Additional ﬂuorescence microscopy data using antibodies
to simultaneously detect both Ski and SMAD4 revealed thats. AeD: Western analysis of Ski in nuclear proteins extracted from HHSCs at
after treatment with either 200 mmol/L acetaldehyde or 8 ng/mL of TGF-b1.
< 0.001 versus control.
1463
Figure 8 Ski and SMAD4 colocalize in the nuclei of
HSCs and translocate to the cytosol after acetaldehyde
administration. A: Immunoﬂuorescence microscopy of
mouse HSCs cultured in the absence or presence of 200
mmol/L acetaldehyde for 30 minutes. Cells were stained
with antibodies to SMAD4 and Ski, followed by the cor-
responding secondary antibodies labeled with ﬂuorescein
isothiocyanate (green) for Ski and Cy3 (red) for SMAD4.
Both Ski and SMAD4 localized in the nuclei of HSCs; yel-
low ﬂuorescence indicates colocalization. After adminis-
tration of acetaldehyde, both proteins are exported to the
cytosol (arrow). However, a fair amount of SMAD4 is
present in the nucleus (red). B: Immunoprecipitation (IP)
of SMAD4, followed by Western analysis for the detection
of Ski in HHSCs cultured in the absence or presence of 200
mmol/L acetaldehyde (B). Results are representative of
three independent experiments. Original magniﬁcation,
40.
Reyes-Gordillo et alSMAD4 is also localized in the nucleus of untreated HSCs.
Moreover, SMAD4 appears to colocalize with Ski, and both
appear to be translocated together to the cytosol after acet-
aldehyde treatment. However, a signiﬁcant amount of
SMAD4 remains in the nucleus, as demonstrated by positive
staining with anti-SMAD4 antibodies (Figure 8A). To
further test whether SMAD4 and Ski interact with each
other, we performed coimmunoprecipitation assays using an
antibody against SMAD4 and then veriﬁed whether Ski
coprecipitated with SMAD4 by Western blot analysis using
Ski antibody. SMAD4 and Ski formed complexes in both
untreated control and acetaldehyde-treated cells (Figure 8B).Lactacystin, an Inhibitor of Proteasomal Degradation,
Inhibits Acetaldehyde-Mediated COL1A2 Promoter-
Driven Reporter Activity and Gene Transcription
Because Ski is degraded by proteasomes,27 we investigated
whether lactacystin, an inhibitor of proteasomal degrada-
tion, has any effect on the levels of Ski and on the level of
response of the 378COL1A2LUC reporter vector to acet-
aldehyde. In HHSCs treated with lactacystin alone, Ski levels
were higher than in control cells (P < 0.05) (Figure 9A).
Furthermore, lactacystin prevented acetaldehyde-mediated
decrease in nuclear Ski by approximately 50% (P < 0.05).
Likewise, lactacystin also prevented acetaldehyde-mediated1464up-regulation of the 378COL1A2LUC reporter vector ac-
tivity by 50% (P < 0.05) (Figure 9B).
To determine the speciﬁcity of this event, we tested the
effect of lactacystin on acetaldehyde-induced transcription
of COL1A2 (Figure 10A) and of FN1, the nonspeciﬁc
ﬁbronectin gene (Figure 10B). Lactacystin prevented
acetaldehyde-mediated up-regulation of COL1A2 by 60%
(P < 0.05), but had no effect on up-regulation of ﬁbronectin
transcription (Figure 10). This is in agreement with our
previous studies suggesting that acetaldehyde-dependent
regulation of collagen and of ﬁbronectin follows different
pathways,9 and that TGF-b1edependent up-regulation of
ﬁbronectin is SMAD independent.28,29Discussion
Acetaldehyde, the ﬁrst metabolite of ethanol, is ﬁbrogenic
and induces expression of both COL1A1 and COL1A2 genes
by a mechanism dependent on the generation of H2O2.
These events are partially reproduced by adding this reactive
oxygen species to cultured HSCs and can be prevented by
the addition of catalase.2,12 Although the mechanisms
whereby acetaldehyde induces generation of H2O2 remain to
be established, our ﬁndings suggest that it may derive from
mitochondrial dysfunction and not from the activation of the
NADP(H) oxidase.12 This suggestion is based on the factajp.amjpathol.org - The American Journal of Pathology
Figure 9 Lactacystin, an inhibitor of proteasomal degradation, inhibits
acetaldehyde-mediated expression of COL1A2 promoter-driven reporter
activity. A: Western analysis of Ski in nuclear proteins extracted from HHSCs
treated with 200 mmol/L acetaldehyde, 30 mmol/L lactacystin, or both. In
HHSCs treated with lactacystin alone, Ski levels were higher than in control
cells. B: HHSCs were transfected with the 378COL1A2LUC reporter vector;
12 hours later, cells were incubated with 30 mmol/L lactacystin. After 30
minutes, acetaldehyde (200 mmol/L ﬁnal concentration) was added; 36
hours later, cells were harvested and luciferase activity was determined.
Controls for these experiments were transfected cells without treatment,
cells treated with lactacystin alone, and cells treated with acetaldehyde
alone. Lactacystin prevented acetaldehyde-mediated decrease in nuclear
Ski by approximately 50% and up-regulation of the 378COL1A2LUC re-
porter vector activity by 50%. Data are expressed as means  SEM.
*P < 0.05 versus control. yP < 0.05 versus lactacystin treated cells.
zP < 0.05 versus acetaldehyde-treated cells.
Figure 10 Lactacystin blocks acetaldehyde-mediated COL1A2 gene
transcription, but not acetaldehyde-mediated ﬁbronectin gene transcrip-
tion. A and B: Lactacystin prevented acetaldehyde-mediated up-regulation
of COL1A2 by 60% (P < 0.05) (A), but had no effect on the up-regulation of
ﬁbronectin transcription (B). Controls are assigned a value of 100%. All
values were corrected for loading differences using an S14 ribosomal pro-
tein cDNA. Data are expressed as means  SEM, representative of three
independent experiments. *P < 0.05 versus control. yP < 0.05 versus
acetaldehyde-treated cells.
Up-Regulation of COL1A2 in HSCsthat phenyliodonium, an inhibitor of NADP(H) oxidase, had
no effect on acetaldehyde-dependent up-regulation of a1(I)
collagen mRNA.30 By contrast, ethanol is well known to
cause mitochondrial alterations and redox changes.9,31
However, these results do not rule out the possibility that
other cell types, such as inﬂammatory and Kupffer cells,
known to express NADP(H) oxidase could contribute to the
overall pool of H2O2 in vivo.
8
Previous work from our laboratory has shown that some
ﬁbrogenic actions of acetaldehyde are mediated and/or
enhanced by TGF-b1.1,12 Acetaldehyde induces expression
and activation of TGF-b1 and of its type II receptor.1,12,16
However, the early events triggered by acetaldehyde occur-
ring within the ﬁrst 6 to 12 hours after acetaldehyde admin-
istration are not dependent on TGF-b1 and protein synthesis.
Furthermore, both acetaldehyde and TGF-b1 stimulate
phosphorylation and binding of SMAD3/4econtainingThe American Journal of Pathology - ajp.amjpathol.orgtranscriptional complexes to the COL1A2 promoter region.12
However, in contrast to the ability of TGF-b1 to up-regulate
expression of SMADs 3 and 4 at the mRNA and protein
levels and to enhance the phosphorylation of SMAD2,32
acetaldehyde has no effect on SMAD2 phosphorylation12
and does not signiﬁcantly up-regulate expression of
SMAD2 protein. In the present study, although neither
acetaldehyde nor TGF-b1 alone had signiﬁcant stimulatory
effect, the combination elicited the maximum additive stim-
ulatory activity of COL1A2 reporter vector (Figure 1).
Overall, these ﬁndings strongly suggest that the ﬁbro-
genic signaling pathways triggered by acetaldehyde and
TGF-b1 are distinctly different. The fact that the stimulatory
effect of acetaldehyde after 24 hours on COL1A2 gene
expression was signiﬁcantly blunted by TGF-b1 neutral-
izing antibody, but not by a nonspeciﬁc antibody (Figure 2),
conﬁrms that acetaldehyde-induced expression of TGF-b1 is
responsible for the up-regulation of COL1A2. That the
concomitant expression of both SMAD3 and SMAD4
(Figure 3) is obligatory for this effect of acetaldehyde on
TGF-b1 expression is shown by the fact that neither
SMAD3 nor SMAD4 vector overexpression alone caused
acetaldehyde-induced stimulation of COL1A2 reporter ac-
tivity, whereas in combination the two SMADs caused
marked stimulation (Figure 4). On the other hand, the ability
of acetaldehyde to up-regulate COL1A2 reporter activity in1465
Reyes-Gordillo et alnormal HSCs, but not in SMAD7-overexpressing HSCs
(Figure 5), indicates that the action of acetaldehyde involves
the suppression of SMAD7, a potent repressor of COL1A2
gene expression.
Our immunocytochemical studies demonstrated that Ski
is preferentially localized in the nuclei of activated HSCs
(Figures 6 and 7) and that acetaldehyde induces trans-
location of the repressor protein Ski from the nucleus to the
cytoplasm by forming a complex with SMAD4 and thereby
leading to the activation of nuclear SMAD4 (Figure 8). The
key repressor role of Ski in the regulation of COL1A2 gene
expression was clearly established (Figures 9 and 10).
Lactacystin, a potent proteasomal inhibitor, blunted
acetaldehyde-dependent up-regulation of COL1A2 gene
transcription and reporter activity of a luciferase vector
driven by the acetaldehyde-responsive element of COL1A2,
but had no effect on the induction of housekeeping ﬁbro-
nectin gene transcription.
Thus, we have shown that, in addition to up-regulating
COL1A2 gene expression by enhancing expression and ac-
tivity of positive transactivators, acetaldehyde also down-
regulates expression of the gene transcription inhibitor
SMAD7. More importantly, acetaldehyde effectively pro-
motes the translocation of the other transcription repressor,
Ski, from the nucleus to the cytoplasmic compartment to
undergo proteasomal degradation via the ubiquitin pathway.
Our ﬁndings suggest that transcriptional up-regulation of
COL1A2 by acetaldehyde occurs via two distinct mecha-
nisms. The ﬁrst occurs very rapidly, is transient, and in-
volves the elimination of repressors of COL1A2 (such as Ski
and SMAD7) and the phosphorylation of SMAD3. The
second mechanism is more sustained and corresponds to the
expression of TGF-b1 and consequent up-regulation of
SMAD3 and SMAD4, a process that starts after 6 to 12 hours
of exposure to acetaldehyde. Based on these new ﬁndings, as
well as on earlier work,16 we speculate that the cytokine
TGF-b1 augments acetaldehyde-dependent expression of
COL1A2. This suggestion is also supported by the fact that
the effects of acetaldehyde and TGF-b1 are additive.
We have shown here that acetaldehyde induces a rapid
down-regulation of SMAD7. This SMAD is a negative
regulator of the COL1A2 gene,24,25 so its decrease occurs at
the time when collagen mRNA is being up-regulated.
Interestingly, the expression of SMAD7 starts to increase
at a time when SMAD3 and SMAD4 are being up-regulated
and reaches its maximal level when the expression of
COL1A2 has leveled off or even started to decrease. These
ﬁndings may explain the up-regulation and down-regulation
of collagen gene expression after a single acetaldehyde dose
of 200 mmol/L. Thus, although collagen mRNA is up-
regulated when repressors are down-regulated, collagen
gene expression is shut down when the repressors return to
normal levels.
The SMAD7 promoter has binding motifs for SMAD3
and SMAD4.33,34 Accordingly, it is conceivable that the up-
regulation of SMAD7 mRNA by acetaldehyde results from1466the late up-regulation of SMAD3 and SMAD4 and subse-
quent binding to the SMAD7 promoter region. Taken
together, our ﬁndings suggest that the regulation of the
COL1A2 by acetaldehyde involves the concerted actions of
several transactivators and repressors, as observed in the
present study. In the basal state, several repressors limit
COL1A2 expression and thus control the amount of type I
collagen present in the normal extracellular matrix. How-
ever, acetaldehyde induces degradation of these repressors,
thus allowing the binding of transcriptional activators
involved in COL1A2 up-regulation. As shown here and
previously,1,11,12 this process occurs via rapid phosphory-
lation of SMAD3 and formation of SMAD3/4 complexes
that interact with Sp1.
In conclusion, based on the present ﬁndings we speculate
that Ski plays a major role in the ﬁbrogenic action of
acetaldehyde by sequestering the SMAD4eSki complex
from the nucleus to the cytoplasm, leading to the protea-
somal degradation of Ski via the ubiquitin pathway and
consequent activation of SMAD4. Activated SMAD4 and
phosphorylated SMAD3, the two key transcription factors,
in turn up-regulate COL1A2 in the nucleus by interacting
with its promoter region. Thus, we suggest that the protea-
somal degradation of Ski is an important event in
acetaldehyde-mediated up-regulation of COL1A2 in HSCs.
The present ﬁndings unveil additional critical steps in the
acetaldehyde-mediated ﬁbrogenic process and thus suggest
possible new targets for antiﬁbrogenic therapy.Acknowledgments
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